Project Grant R41CA278032
Award Date 9/2/25
Completion Date 8/31/26
Dollars Obligated $400K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
- The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...
- The University of Michigan has been awarded a $568,151 Project Grant from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to develop a real-time functional imaging platform for accurate diagnosis and prognosis of prostate cancer. The project aims to leverage photoacoustic imaging and biocompatible hydrogel nanoparticle probes to quantitatively assess prostate gland microarchitecture and tumor microenvironment as imaging biomarkers for improved prostate...
- This $681,215 federal Project Grant was awarded on September 1, 2025 by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to New York University (NYU) to develop AI-powered diagnostic tools for early prostate cancer detection. The project aims to leverage machine learning models to infer the presence of clinically significant prostate cancer using a minimal amount of degraded MRI data, in order to enable widespread, cost-effective population-level disease...
- The National Cancer Institute (NCI) awarded a $400,000 Project Grant under CFDA 93.394 (Cancer Detection and Diagnosis Research) to O2M Technologies LLC to develop a Multifunctional Imager (MFI) that can simultaneously acquire tissue oxygen pressure (pO2) and pH maps using electron paramagnetic resonance imaging (EPRI) techniques. The 12-month project aims to create a 25 MT Halbach-type permanent magnet, new multi-modal transmit-receive electronics, and the integrated MFI instrument. This...
- This Project Grant award, provided by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), supports a transformative research project aimed at enhancing prostate cancer (PCA) prognostication through the integration of epithelial-to-mesenchymal transition (EMT) signature markers with advanced imaging and machine learning techniques. The $399,954 award to Metastx LLC will enable analysis of PCA tissue samples to develop a novel predictive model for metastatic...
- This federal Project Grant award, valued at $306,872 and provided by the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), aims to develop a new imaging system termed the Multi-Camera Array Scanner (MCAS). The MCAS will enable rapid 3D digitization and automated analysis of thick fine-needle aspiration (FNA) cytology smears, which are a critical first step in the cancer diagnosis pipeline. The project is a collaboration between Ramona Optics Inc., a small...
- This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $512,728 to The Johns Hopkins University to develop a new ultrasound probe and robot system, called PROBOT, for improving prostate cancer image-guided interventions. The key products and services delivered through this funding include: Development and evaluation of a novel ultrasound probe and robot system specifically designed for prostate cancer biopsy and focal...
- The University of Miami was awarded a $538,553 federal Project Grant from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to conduct longitudinal research on the use of quantitative multiparametric MRI (mpMRI) features and circulating tumor cells (CTCs) as early markers of treatment outcomes for prostate cancer patients receiving radiotherapy and androgen deprivation therapy (ADT). The goal of the 5-year research project is to define the role of mpMRI and...
- This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund research to develop a minimally invasive, plasma-based diagnostic method for early detection of prostate cancer in African American men. The $475,759 award to The Children's Hospital Corporation (Boston Children's Hospital) will support the investigation of two next-generation sequencing-based methods - cell-free DNA fragmentation profiling and...
- The National Science Foundation (NSF) awarded a $305,000 Small Business Innovation Research (SBIR) Phase I project grant to Segmedix, CO. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop an AI-powered software system to improve the accuracy, consistency, and efficiency of prostate cancer diagnosis using magnetic resonance imaging (MRI). Specifically, the project will create a style-encoding generative adversarial network (GAN) to harmonize...